Rohan Hockings says there are 10 times as many drug targets inside a cell wall as on the surface. Photo: Attila Csaszar

No hard cell for Phylogica

Phylogica has a new chief executive who is determined to bring the Perth biotech’s commercialisation strategy to fruition.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®